HK Stock MarketDetailed Quotes
02500 VENUS MEDTECH-B
- 5.620
- 0.0000.00%
Market Closed Nov 15 16:08 CST
2.48BMarket Cap-4040P/E (TTM)
0.000High0.000Low0Volume0.000Open5.620Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)441.01MShares5.94052wk High0.83P/B2.48BFloat Cap5.03052wk Low--Dividend TTM441.01MShs Float97.000Historical High--Dividend LFY0.00%Amplitude3.740Historical Low--Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
VENUS MEDTECH-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 42.33%-213.58M | 36.41%-735.34M | -50.30%-370.34M | -206.27%-1.16B | -110.22%-246.41M | -103.16%-377.56M | -169.27%-117.21M | 51.29%-185.84M | 76.57%-43.53M | -27.34%-381.54M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 59.74%-4.62M | 0.55%-34.46M | -32.81%-11.47M | 29.98%-34.65M | 64.18%-8.64M | -42.73%-49.48M | -24.61%-24.11M | -462.50%-34.67M | -11,346.75%-19.35M | -599.55%-6.16M |
| Attributable subsidiary (profit) loss | -90.80%641K | -11.20%12.38M | -52.28%6.96M | 19.06%13.94M | 123.72%14.59M | 2,154.56%11.71M | 2,361.51%6.52M | ---570K | --265K | ---- |
| Impairment and provisions: | -108.06%-741K | -40.23%264.21M | 571.71%9.19M | 85.90%442M | -65.16%1.37M | 9,557.19%237.76M | 50.77%3.93M | -10.93%2.46M | 134.81%2.6M | 22.74%2.76M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --4.2M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | 104.93%23K | 8,830.69%17.64M | 79.03%-467K | 85.91%-202K | -404.65%-2.23M | -157.09%-1.43M | -55.83%731K | 324.32%2.51M | --1.66M | 2.60%592K |
| -Impairment of trade receivables (reversal) | -107.91%-764K | -110.06%-2.21M | 168.60%9.66M | 620.87%21.97M | 12.52%3.6M | 6,196.00%3.05M | 236.67%3.2M | -102.30%-50K | -14.43%949K | 29.67%2.17M |
| -Impairment of goodwill | ---- | -24.00%231.26M | ---- | 60.19%304.3M | ---- | --189.96M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -84.32%17.52M | ---- | 141.91%111.74M | ---- | --46.19M | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -426.30%-181.87M | -846.03%-5.96M | 122.44%55.74M | 93.06%-630K | -462.92%-248.41M | -9,881.32%-9.08M | ---44.13M | ---91K | ---- |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | 77.31%-10.01M | ---10.01M | ---44.13M | ---- | ---- |
| -Other fair value changes | ---- | -426.30%-181.87M | -846.03%-5.96M | 123.38%55.74M | -167.67%-630K | ---238.39M | 1,123.08%931K | ---- | ---91K | ---- |
| Asset sale loss (gain): | -101.46%-3K | 873.08%1.27M | -54.75%205K | 622.22%130K | 5,562.50%453K | -96.79%18K | -98.56%8K | 1,500.00%560K | 2,826.32%556K | -87.68%35K |
| -Loss (gain) on sale of property, machinery and equipment | -101.46%-3K | 873.08%1.27M | -54.75%205K | 622.22%130K | 5,562.50%453K | -96.79%18K | -98.56%8K | 1,500.00%560K | 2,826.32%556K | -87.68%35K |
| Depreciation and amortization: | 4.34%58.49M | 11.07%124.79M | 2.76%56.06M | 117.65%112.35M | 149.81%54.55M | 36.88%51.62M | 22.27%21.84M | 30.46%37.71M | 35.34%17.86M | 187.82%28.91M |
| -Amortization of intangible assets | -2.64%24.96M | -7.84%53.37M | -23.03%25.63M | 157.93%57.91M | 245.34%33.3M | 33.69%22.45M | 40.12%9.64M | 29.35%16.79M | 7.87%6.88M | 250.80%12.98M |
| Financial expense | -68.56%9.81M | 40.55%62.72M | 70.68%31.19M | 2,242.41%44.62M | 1,756.81%18.27M | -54.34%1.91M | -67.99%984K | -80.97%4.17M | -69.44%3.07M | 579.90%21.92M |
| Exchange Loss (gain) | -117.23%-3.64M | 97.24%-2.26M | 96.42%-1.68M | -293.56%-81.73M | -365.09%-46.82M | -56.23%42.22M | 202.07%17.66M | 946.91%96.46M | -70.84%-17.3M | -1,008.96%-11.39M |
| Special items | 298.21%111K | 16.98%-572K | -109.64%-56K | -606.62%-689K | --581K | 135.51%136K | ---- | -100.32%-383K | ---- | -48.80%120.71M |
| Operating profit before the change of operating capital | 46.30%-153.54M | 19.10%-489.15M | -34.43%-285.9M | -83.18%-604.62M | -113.83%-212.67M | -165.69%-330.07M | -77.89%-99.46M | 44.73%-124.23M | 45.30%-55.91M | -349.60%-224.77M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 16.85%-10.76M | -91.46%-26.18M | 4.71%-12.95M | 53.14%-13.68M | -93.08%-13.59M | 22.45%-29.18M | 52.25%-7.04M | -332.69%-37.63M | -1,236.96%-14.74M | -10.86%-8.7M |
| Accounts receivable (increase)decrease | 115.40%16.52M | 230.54%14.21M | -184.16%-107.26M | 88.59%-10.89M | 72.70%-37.75M | -34.77%-95.42M | -8,213.89%-138.26M | 18.71%-70.8M | 97.19%-1.66M | -22.43%-87.1M |
| Accounts payable increase (decrease) | -35.96%35.32M | 222.86%53.12M | 223.18%55.15M | -748.26%-43.24M | 45.59%17.07M | 77.79%-5.1M | 120.16%11.72M | -208.93%-22.95M | -1,168.05%-58.13M | 173.55%21.07M |
| prepayments (increase)decrease | -40.02%16.78M | 138.14%17.37M | 176.12%27.98M | -163.91%-45.56M | -693.63%-36.75M | -4,448.36%-17.26M | -11.94%-4.63M | 103.68%397K | 61.91%-4.14M | -219.15%-10.8M |
| Special items for working capital changes | 661.37%174.02M | -507.38%-175.95M | 488.62%22.86M | -24,650.00%-28.97M | -52.29%3.88M | 101.33%118K | 2,047.13%8.14M | -208.90%-8.85M | -106.35%-418K | -10.75%8.13M |
| Cash from business operations | 126.10%78.34M | 18.79%-606.58M | -7.26%-300.13M | -56.62%-746.94M | -21.91%-279.81M | -80.61%-476.92M | -70.02%-229.53M | 12.61%-264.06M | 15.01%-135M | -98.92%-302.16M |
| Other taxs | 109.89%423K | -12.15%-3.44M | -161.19%-4.28M | 64.50%-3.07M | 909.97%6.99M | -57.96%-8.65M | 79.93%-863K | -9.39%-5.47M | -148.35%-4.3M | ---5M |
| Interest received - operating | -56.50%3.49M | ---- | -7.16%8.02M | -28.24%20.55M | -64.18%8.64M | -11.95%28.64M | 31.45%24.11M | 739.27%32.53M | 10,750.89%18.34M | 793.09%3.88M |
| Net cash from operations | 127.75%82.25M | 16.37%-610.02M | -12.19%-296.39M | -59.65%-729.46M | -28.07%-264.19M | -92.79%-456.92M | -70.54%-206.28M | 21.86%-237.01M | 24.59%-120.96M | -100.24%-303.29M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -67.28%1.13M | 778.30%21.29M | 6,411.32%3.45M | -83.84%2.42M | --53K | --15M | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | -1,395.63%-82.14M | -2,838.10%-82.14M | 258.50%6.34M | --3M | 57.89%-4M | ---- | ---9.5M | ---70.58M | ---- |
| Decrease in deposits (increase) | --7.24M | ---7.24M | ---- | ---- | ---299M | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | 105.79%747K | -69.04%2.91M | --363K | --9.41M | ---- | ---- | ---- | 966.67%32K | --32K | -94.00%3K |
| Purchase of fixed assets | 18.26%-43.56M | -53.33%-260.64M | 58.69%-53.29M | -107.12%-169.98M | -445.15%-128.99M | -64.86%-82.07M | -74.92%-23.66M | -216.90%-49.78M | -202.28%-13.53M | -4.79%-15.71M |
| Purchase of intangible assets | -52.50%-2.68M | 74.16%-2.27M | 97.17%-1.76M | 55.37%-8.79M | -2,136.16%-62.21M | 73.47%-19.71M | 64.10%-2.78M | -742.01%-74.27M | -1,094.14%-7.75M | 23.58%-8.82M |
| Acquisition of subsidiaries | ---- | ---- | ---- | -552.93%-813.49M | ---944.69M | -128.15%-124.59M | ---- | -747.59%-54.61M | -747.59%-54.61M | 96.65%-6.44M |
| Recovery of cash from investments | ---- | --22.27M | --25.64M | ---- | ---- | --54.14M | --54.14M | ---- | ---- | ---- |
| Cash on investment | ---- | 58.19%-41.04M | 38.74%-40.94M | 80.91%-98.17M | 51.88%-66.84M | -368.33%-514.31M | -117.10%-138.89M | ---109.82M | ---63.98M | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | --22.5M | ---- | ---- | ---297K | ---- |
| Net cash from investment operations | 75.03%-37.13M | 67.65%-346.86M | 90.08%-148.68M | -64.20%-1.07B | -1,247.78%-1.5B | -119.18%-653.04M | 47.23%-111.2M | -862.07%-297.94M | -1,721.60%-210.7M | 84.05%-30.97M |
| Net cash before financing | 110.14%45.12M | 46.89%-956.88M | 74.75%-445.07M | -62.32%-1.8B | -455.27%-1.76B | -107.49%-1.11B | 4.28%-317.48M | -60.04%-534.95M | -92.87%-331.66M | 3.28%-334.26M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -56.47%79.53M | -55.97%413.48M | -79.23%182.68M | --939.14M | --879.45M | ---- | ---- | ---- | -99.08%985K | 87.77%107.03M |
| Refund | -81.08%-389.83M | -140.69%-513.58M | -23,819.89%-215.28M | -4,440.02%-213.38M | ---900K | 96.08%-4.7M | ---- | -79.71%-120M | -300.00%-120M | -75.85%-66.77M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | 15.18%1.19B | --1.19B | -61.39%1.03B | ---- | --2.68B |
| Interest paid - financing | 63.63%-10.23M | -40.82%-61.69M | -65.77%-28.12M | -1,678.63%-43.81M | -1,623.78%-16.96M | 88.65%2.78M | 30.16%-984K | 116.38%1.47M | 67.60%-1.41M | -190.17%-8.98M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | 112.50%42.5M | --22.5M | -93.52%20M | ---- | -30.69%308.64M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---72.55M | ---- | ---- | ---- | ---154.59M |
| Pledged bank deposit (increase) decrease | ---- | 179.33%18.04M | ---- | ---22.74M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | 15,956.68%247.59M | ---- | 100.55%1.54M | 370.37%5.31M | -4,094.43%-278.8M |
| Net cash from financing operations | -364.82%-337.97M | -127.39%-173.99M | -108.53%-72.71M | -54.35%635.14M | -29.17%852.39M | 49.98%1.39B | 1,106.45%1.2B | -64.00%927.75M | -131.75%-119.58M | 468.74%2.58B |
| Effect of rate | -62.66%4.3M | -71.56%25.83M | -84.95%11.51M | 363.94%90.81M | 631.46%76.51M | 64.85%-34.4M | -268.54%-14.4M | -1,966.29%-97.89M | 804.87%8.54M | 416.92%5.25M |
| Net Cash | 43.44%-292.85M | 3.06%-1.13B | 43.13%-517.78M | -514.50%-1.17B | -202.76%-910.46M | -28.35%281.45M | 296.35%886M | -82.49%392.8M | -320.46%-451.24M | 1,985.55%2.24B |
| Begining period cash | -58.80%774.4M | -36.40%1.88B | -36.40%1.88B | 9.12%2.96B | 9.12%2.96B | 12.22%2.71B | 12.22%2.71B | 1,363.34%2.41B | 1,363.34%2.41B | 179.44%164.91M |
| Cash at the end | -64.62%485.84M | -58.80%774.4M | -35.27%1.37B | -36.40%1.88B | -40.74%2.12B | 9.12%2.96B | 81.66%3.58B | 12.22%2.71B | 431.81%1.97B | 1,363.34%2.41B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | --3.58B | ---- | ---- | --622.44M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | --3.58B | ---- | ---- | --622.44M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhonghui Certified Public Accountants | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data